Evidence map›Paper›PMID 36671537›Full record

ArticleBiomolecules2023

FK506-Binding Protein 2 Participates in Proinsulin Folding.

Carolin Hoefner, Tenna Holgersen Bryde, Celina Pihl, Sylvia Naiga Tiedemann, Sophie Emilie Bresson, Hajira Ahmed Hotiana, Muhammad Saad Khilji, Theodore Dos Santos, Michele Puglia, Paola Pisano and 15 more

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 6 institutions in 6 countries.

Carolin HoefnerInflammation, Metabolism and Oxidation Section, Department of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.ORCID 0000-0002-4180-2144
Tenna Holgersen BrydeInflammation, Metabolism and Oxidation Section, Department of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.ORCID 0000-0003-3422-2122
Celina PihlInflammation, Metabolism and Oxidation Section, Department of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.ORCID 0000-0002-0848-9096
Sylvia Naiga TiedemannInflammation, Metabolism and Oxidation Section, Department of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
Sophie Emilie BressonInflammation, Metabolism and Oxidation Section, Department of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.ORCID 0000-0002-8623-2237
Hajira Ahmed HotianaDepartment of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
Muhammad Saad KhiljiInflammation, Metabolism and Oxidation Section, Department of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.ORCID 0000-0001-6230-9327
Theodore Dos SantosDepartment of Pharmacology and Alberta Diabetes Institute, University of Alberta, Edmonton, AB T6G 2E1, Canada.ORCID 0000-0002-9761-3609
Michele PugliaProteomics Research Infrastructure, University of Copenhagen, 2200 Copenhagen, Denmark.
Paola PisanoProteomics Research Infrastructure, University of Copenhagen, 2200 Copenhagen, Denmark.
Mariola MajewskaDepartment of Genetics, Institute of Experimental Biology, Faculty of Biology, Adam Mickiewicz University, 61-712 Poznań, Poland.
Julia DurzynskaDepartment of Genetics, Institute of Experimental Biology, Faculty of Biology, Adam Mickiewicz University, 61-712 Poznań, Poland.ORCID 0000-0002-8767-3755
Kristian KlindtInflammation, Metabolism and Oxidation Section, Department of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
Justyna KlusekLaboratory of Medical Genetics, Department of Surgical Medicine, Collegium Medicum, Jan Kochanowski University, 25-406 Kielce, Poland.ORCID 0000-0002-1098-8919
Marcelo J PeroneImmuno-Endocrinology, Diabetes & Metabolism Laboratory, Instituto de Investigaciones en Medicina Traslacional, Facultad de Ciencias Biomédicas, CONICET-Universidad Austral, Buenos Aires B1629AHJ, Argentina.
Robert BuckiDepartment of Medical Microbiology and Nanobiomedical Engineering, Medical University of Białystok, 15-089 Białystok, Poland.
Per Mårten HägglundInflammation, Metabolism and Oxidation Section, Department of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.ORCID 0000-0002-6627-7518
Pontus Emanuel GourdonDepartment of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.ORCID 0000-0002-8631-3539
Kamil GotfrydDepartment of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.ORCID 0000-0002-0299-0779
Edyta UrbaniakInstitute of Molecular Biology and Biotechnology, Faculty of Biology, Adam Mickiewicz University, 61-712 Poznań, Poland.
Malgorzata BorowiakInstitute of Molecular Biology and Biotechnology, Faculty of Biology, Adam Mickiewicz University, 61-712 Poznań, Poland.
Michael WiererProteomics Research Infrastructure, University of Copenhagen, 2200 Copenhagen, Denmark.
Patrick Edward MacDonaldDepartment of Pharmacology and Alberta Diabetes Institute, University of Alberta, Edmonton, AB T6G 2E1, Canada.ORCID 0000-0002-5439-6288
Thomas Mandrup-PoulsenInflammation, Metabolism and Oxidation Section, Department of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.ORCID 0000-0002-3215-9273
Michal Tomasz MarzecInflammation, Metabolism and Oxidation Section, Department of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.ORCID 0000-0001-9698-6019
University of Copenhagen · DKAdam Mickiewicz University in Poznań · PLUniversity of Alberta · CAConsejo Nacional de Investigaciones Científicas y Técnicas · ARJan Kochanowski University · PLMedical University of Białystok · PL

Funding

Visiting Professorship from the Danish Diabetes Academy NNF17SA0031406
6 · The paper itself

Abstract

Apart from chaperoning, disulfide bond formation, and downstream processing, the molecular sequence of proinsulin folding is not completely understood. Proinsulin requires proline isomerization for correct folding. Since FK506-binding protein 2 (FKBP2) is an ER-resident proline isomerase, we hypothesized that FKBP2 contributes to proinsulin folding. We found that FKBP2 co-immunoprecipitated with proinsulin and its chaperone GRP94 and that inhibition of FKBP2 expression increased proinsulin turnover with reduced intracellular proinsulin and insulin levels. This phenotype was accompanied by an increased proinsulin secretion and the formation of proinsulin high-molecular-weight complexes, a sign of proinsulin misfolding. FKBP2 knockout in pancreatic β-cells increased apoptosis without detectable up-regulation of ER stress response genes. Interestingly, FKBP2 mRNA was overexpressed in β-cells from pancreatic islets of T2D patients. Based on molecular modeling and an in vitro enzymatic assay, we suggest that proline at position 28 of the proinsulin B-chain (P28) is the substrate of FKBP2's isomerization activity. We propose that this isomerization step catalyzed by FKBP2 is an essential sequence required for correct proinsulin folding.

Indexed as

Insulin-Secreting CellsProinsulinEndoplasmic ReticulumInsulinMolecular ChaperonesProlineProtein FoldingTacrolimus Binding ProteinsInsulinMolecular ChaperonesProinsulinProlineTacrolimus Binding Proteinsendoplasmic reticulumFKBP2proinsulinproline isomerization

Identifiers

PMID36671537
PMCPMC9855983
OpenAlexW4315795805

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.